Diffuse large B-cell lymphoma that develops in the setting of long-standing chronic inflammation is typically associated with Epstein-Barr virus, and usually presents as tumor mass involving body cavities, as in pyothorax-associated lymphoma. It is listed as a distinct entity in the latest World Health Organization lymphoma classification. We report four cases that were incidentally discovered on histologic examination, one each in a splenic false cyst, a long-standing hydrocele, an atrial myxoma, and metallic-implant wear debris. Microscopic foci of atypical (neoplastic) large lymphoid cells were found within the contents of the cysts or curettage material, or within the stroma of the atrial myxoma. Despite the diverse clinical scenarios, all cases showed a homogeneous phenotype: positivity for B-lineage markers (CD20 þ , CD79a þ , PAX5 þ ), non-germinal center immunophenotype (CD10À, BCL6À/ þ , MUM-1 þ ), and positivity for Epstein-Barr virus with type III latency (LMP1 þ , EBNA2 þ ). The last feature supports the hypothesis that the lymphoma has arisen in a setting of 'local immunodeficiency' as a result of long-standing chronic inflammation in an enclosed space, a characteristic pathogenetic mechanism of diffuse large B-cell lymphoma associated with chronic inflammation. These cases therefore expand the spectrum of this entity to include new clinical scenarios for the development of this lymphoma type.
In 1987, Iuchi et al 1 first reported three cases of pleural B-cell lymphoma in Japanese patients with chronic pyothorax resulting from artificial pneumothorax for treatment of pulmonary tuberculosis or tuberculous pleuritis. Non-autoimmune type of chronic inflammatory stimulus was suggested as an etiology. Subsequently, many more cases have been reported in Japanese patients, under the designation 'pyothorax-associated lymphoma' (PAL). 2, 3 This lymphoma type has also been uncommonly reported in Western patients. [4] [5] [6] [7] It shows features of diffuse large B-cell lymphoma (DLBCL) exhibiting consistent association with Epstein-Barr virus (EBV). 8, 9 Lymphomas with similar features are also recognized to develop in other chronic inflammatory conditions, such as use of metallic implants in bones and joints, 10 chronic osteomyelitis, 11 chronic venous ulcer, 11 and use of surgical mesh implant. 12 In 2008, the World Health Organization classification of tumors of hematopoietic and lymphoid tissues has adopted 'DLBCL associated with chronic inflammation' as a distinct entity and unifying concept for this group of lymphomas. 13 We report four cases discovered incidentally in long-standing pathologic lesions, which contrast with the presence of frank tumor masses in the typical cases of DLBCL associated with chronic inflammation. These cases also broaden the clinical scenarios for the development of this lymphoma type.
Materials and methods

Patients and Pathologic Materials
The four cases were collected from Queen Mary Hospital and Queen Elizabeth Hospital of Hong Kong, as well as Tan Tock Seng Hospital of Singapore. All represented lymphomas were found incidentally on microscopic examination of excision specimens. Case 4 has been reported earlier, 10 but clinical information was updated, and additional immunostains were performed.
The surgical specimens were fixed in buffered formalin and processed routinely. Paraffin sections were stained with hematoxylin-eosin (H&E).
Immunohistochemistry
Immunohistochemical staining was performed on deparaffinized tissue sections using a labeled streptavidin-biotin peroxidase or polymer detection system on automated immunostainers (Ventana Medical System, Tucson, AZ, USA or BOND-MAX, Vision BioSystems, Australia), according to the protocols of the manufacturers. After heat-induced antigen retrieval, the tissue sections were immunostained with a panel of antibodies as listed in Table 1 .
Molecular Studies
Paraffin sections were studied for the presence of EBV and immunoglobulin light chain restriction by in situ hybridization for EBV-encoded early small nuclear RNAs (EBER), kappa light chain mRNA, and lambda light chain mRNA. The tests were performed by BOND-MAX automated immunostainer. After digestion with enzyme, the slides were incubated with specific fluorescein-conjugated probes, followed by anti-fluorescein antibody, polymer conjugated with peroxidase and anti-rabbit/mouse IgG, and diaminobenzidine solution.
In cases 3 and 4, DNA was extracted from paraffinembedded material (selected for areas rich in atypical large lymphoid cells), and studied for immunoglobulin gene rearrangement by polymerase chain reaction (PCR), using primers against framework 2 and framework 3, as described earlier. 
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Results
Clinical Findings
The clinical features are summarized in Table 2 . All patients were Chinese, with ages ranging from 29 to 88 years. None had a known history of lymphoma. They all underwent excision of their presenting conditions. One patient (case 2) was lost to followup after operation. The other three patients did not show evidence of lymphoma on postoperative staging work up. They received postoperative anti-CD20 (rituximab) with or without chemotherapy, or local radiation. One patient died from opportunistic infection after chemotherapy at 5 months; two were alive with no evidence of disease at 6 months and 7 years, respectively.
Pathologic Findings
Case-specific features In case 1, the enlarged spleen weighed 900 g, with most of the parenchyma replaced by an 18-cm cyst.
The cyst had a fibrous wall measuring 0.5 cm thick, with old blood and brownish material adherent to the luminal side ( Figure 1a) . Histologically, the cyst wall consisted of hyalinized fibrous tissue with dystrophic calcification and patchy chronic inflammatory cell infiltration ( Figure 1b ). The cyst was devoid of epithelial lining, and it contained hemorrhagic and necrotic material, hemosiderin pigment, and cholesterol crystals, in keeping with previous hemorrhage. The morphology was compatible with splenic false cyst. In 8 of the 23 sampled blocks, small aggregates of atypical large lymphoid cells were seen within inner fibrous zone or necrotic material, with each aggregate measuring no more than 1.5 mm (Figure 1c ). The compressed rim of splenic parenchyma showed unremarkable red and white pulp. In case 2, the testis was atrophic, and the paratesticular abscess tissue measured 10.5 Â 8 Â 5.5 cm. Histologically, the paratesticular tissue showed dense fibrous pseudocapsule with central necrotic debris, proteinaceous material, cholesterol crystals, and mixed acute and chronic inflammatory infiltrate (Figure 2a ). In 1 of the 20 sampled blocks, clusters of atypical large lymphoid cells were found within the central necrotic debris (Figure 2b ).
In case 3, the polypoid left atrial tumor measured 6.5 cm in diameter. Microscopy showed a typical cardiac myxoma, characterized by single or cords of spindly or stellate tumor cells suspended in a myxoid stroma, and immunoreactivity for calretinin (Figures 3a and b) . Multiple tiny aggregates of large lymphoid cells (largest focus 1 mm in diameter) were scattered within the stroma of the cardiac myxoma, in 10 of the 14 sampled blocks (Figure 3c) .
In case 4, the wear debris showed mainly necrotic material, and hyalinized fibrous tissue with abundant 
Morphology of lymphoma cells
The atypical large lymphoid cells found in the four cases occurred singly or in small aggregates. They had irregularly folded or oval nuclei, distinct nucleoli, and a moderate amount of amphophilic cytoplasm (Figures 1c, 2b , and 3d). Some had segmented or binucleated nuclei (Figure 3d ). Some cells appeared degenerated or necrotic (Figure 2b ).
Immunohistochemistry
The immunohistochemical results are summarized in Table 3 . The large lymphoid cells were B-cells expressing CD20, CD79a, and PAX5 (Figures 1d, 2c , and 3e). All cases showed a non-germinal center immunophenotype (CD10À, BCL6À/ þ , MUM-1 þ ). The cells were highly proliferative, with Ki67 index ranging from 70 to 100%. All cases were positive for EBV LMP-1 and EBNA-2 ( Figure 1d ). Cases 1, 3, and 4 showed aberrant expression of CD43. Case 2 also expressed CD3 (Figure 2d ), but other T-cell markers including CD2, CD5, and CD7 were all negative.
Molecular Studies
The lymphoma cells were diffusely positive for EBER on in situ hybridization (Figure 3f ). Kappa light chain mRNA restriction was shown in cases 1 and 3. The lymphoma cells did not show labeling for 
Discussion
This report describes four unusual cases of lymphoma incidentally found in various chronic pathologic lesions. The interpretation of the microscopic aggregates of large lymphoid cells as lymphoma cells is based on the presence of definite cytologic atypia, aberrant immunophenotype (CD43 coexpression in all three tested cases), immunoglobulin light chain restriction (2 of 4 cases), very high proliferative index, uniform labeling of the large lymphoid cells for EBV, and immunoglobulin gene rearrangement (2 of 2 cases). All cases were primary localized lymphomas, as subsequent investigations did not show involvement of other organs. Despite the diverse clinical scenarios, they conform to DLBCL associated with chronic inflammation, 13 as supported by the following findings: (1) occurrence in an enclosed environment, (2) clinical or histologic evidence of long-standing or slow-growing lesion with chronic inflammation, (3) morphologic features of DLBCL, (4) B-cell immunophenotype, and (5) association with EBV. Besides the incidental discovery, these cases differ from the usual lymphomas reported in the respective organs.
Although the spleen is commonly involved by lymphoma, 15 cystic presentation is unusual except secondary to tumor necrosis, infection, or hemorrhage. 16 In contradistinction to splenic DLBCL with infarction followed by cystic degeneration, case 1 shows features typical of splenic false cyst (young patient age and a zoned architecture), 17 the viable lymphoma cells are found in the inner Chronic inflammation-associated B-cell lymphoma fibrous zone rather than the peripheral zone of the cyst wall, and EBV is positive with type III latency (see discussion below).
Likewise, case 2, with a long history of hydrocele, differs from the uncommon primary paratesticular lymphomas, which typically present with solid tumor or enlarged epididymis. [18] [19] [20] [21] [22] In the rare reported cases of testicular plasmacytoma associated with hydrocele, the neoplasm formed a tumorous mass and the hydrocele occurred as a complication instead of being a preexisting condition. 23 Primary cardiac lymphomas are extremely rare in immunocompetent patients. 24 Exceptional cases can mimic cardiac myxoma clinically. 25, 26 In case 3, the cardiac myxoma may have provided the 'soil' for the chronic inflammation, as cardiac myxoma can produce proinflammatory cytokines and be associated with systemic inflammatory symptoms. 27 Recently, Bagwan et al 28 reported two cases of incidental DLBCL, one in a valvular homograft and one in an atrial myxoma, quite similar to case 3. However, both cases showed a germinal center cell immunophenotype instead, and one tested case was negative for EBV-LMP1. As results on EBER and EBNA-2 are not available, it is unclear whether these two cases represent DLBCL associated with chronic inflammation.
Primary bone lymphomas are mostly DLBCLs, which arise de novo and lack association with EBV. However, the cases associated with osteomyelitis or metallic implant show distinctive features as in case 4, such as long latency between onset of inflammatory process and development of lymphoma, and association with EBV. 10 All four cases in this series show a consistent nongerminal center cell immunophenotype, similar to the findings in PAL, 7 the prototype of DLBCL associated with chronic inflammation. Also similar to PAL, 3,7-9,29 all four cases express both LMP-1 and EBNA-2, indicating a type III EBV latency. EBVassociated lymphomas may exhibit type I latency (LMP-1 and EBNA-2 negative), such as Burkitt lymphoma; type II latency (LMP-1 positive, EBNA-2 negative), such as Hodgkin lymphoma, peripheral T-cell lymphoma, and extranodal NK/T cell lymphoma; and type III latency (LMP-1, EBNA-2, EBNA-3 positive), such as posttransplant lymphoproliferative disorder, PAL, and some cases of EBV þ DLBCL of the elderly (postulated to be related to senescence-associated decline in immunocompetence). 30, 31 That is, type III EBV latency is the hallmark of EBV-associated lymphomas arising in the setting of immunodeficiency. As EBNA-2 and EBNA-3 are highly immunogenic, lymphoma cells bearing these proteins would have been eliminated by EBV-specific cytotoxic T lymphocytes if the latter had not been drastically reduced as a result of immunodeficiency. 32 In DLBCL associated with chronic inflammation, it has been postulated that local rather than systemic immunosuppression has an important function in its pathogenesis. Cytokines derived from the chronic inflammatory cells, EBV-immortalized B-cells or lymphoma cells can build up to high levels in the enclosed space. For example, interleukin-10, which inhibits T-cell proliferation through inhibition of monocytemacrophage antigen presenting cells and cytokine production, 32, 33 may contribute to the local immunosuppressive effects. 34, 35 The dense fibrosis of the cyst walls, intra-cardiac myxoma localization, or intra-articular location may also provide an enclosed environment permitting the EBV-infected memory B-cells to evade T-cell immunosurveillance. Coupled with the stimulatory effects of other cytokines such as interleukin-6, EBV-infected cells can accumulate genetic alterations for clonal selection with subsequent evolution to lymphoma. 34, [36] [37] [38] One of the four cases (case 2) shows aberrant expression of the T-cell antigen CD3. Of interest, among the small numbers of cases of CD3-positive B-cell lymphomas reported in the literature, 7, 39, 40 PAL accounts for a significant fraction. The 'local immunodeficiency' may promote this dual immunophenotype, akin to the increased frequency of biphenotypic or bigenotypic lymphomas that occur in the setting of immunodeficiency, and which are often associated with EBV. 39, 41 It is likely that DLBCL associated with chronic inflammation will also be incidentally found in other comparable settings, such as in long-standing thyroid cyst, ovarian cyst, or pancreatic pseudocyst. The optimal treatment for these incidental DLBCLs in contrast to the generally aggressive DLBCLs associated with chronic inflammation that present with frank tumors remains unclear. Although the current standard treatment for localized extranodal DLBCL (stage IE-IIE) is R-CHOP (rituximab, cyclophosphamide, adriamycin, vincristine, and prednisone) chemotherapy, usually followed by involved Chronic inflammation-associated B-cell lymphoma field radiation, 42 this may represent over-treatment for such miniscule tumor volume, especially as the lymphoma might have been totally removed with the diseased organ or pathological lesion. 
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